Expertise in
1
conditions

Guillaume Vogin

UMR 7365 CNRS UL IMoPA, Campus Brabois Santé, 9 Avenue De La Forêt De Haye, BP 20199, 
Nancy, FR 
Expertise in
1
conditions
UMR 7365 CNRS UL IMoPA, Campus Brabois Santé, 9 Avenue De La Forêt De Haye, BP 20199, 
Nancy, FR 

Overview

Guillaume Vogin practices practicing medicine in Nancy, France.

Mr. Vogin is highly rated in 1 condition, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Familial Hypopituitarism, Chordoma, Bone Tumor, and Prostatectomy.

He is actively involved in clinical research, co-authoring 66 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

UMR 7365 CNRS UL IMoPA, Campus Brabois Santé, 9 Avenue De La Forêt De Haye, BP 20199, Nancy, 54505, France
Other Locations
Vandoeuvre-les-nancy, 54505, France
Dijon, 27877, France
Lyon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: March 30, 2026
Intervention Type: Drug
Study Drugs: Intensified Protocol, Stupp Protocol
Study Phase: Phase 3
Radiotherapy of Multiple Brain Metastases Using AGuIX® Gadolinium-chelated Polysiloxane Based Nanoparticles: a Prospective Randomized Phase II Clinical Trial.
Radiotherapy of Multiple Brain Metastases Using AGuIX® Gadolinium-chelated Polysiloxane Based Nanoparticles: a Prospective Randomized Phase II Clinical Trial.
Enrollment Status: Unknown
Publish Date: June 14, 2024
Intervention Type: Radiation, Drug
Study Drug: AGulX
Study Phase: Phase 2
View 1 Less Clinical Trial

66 Total Publications

Non-coding (nc) RNAs and breast cancer treatment related sequelae: Current evidence and perspectives.
Non-coding (nc) RNAs and breast cancer treatment related sequelae: Current evidence and perspectives.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 23, 2025

Frequently Asked Questions about Guillaume Vogin

Is Guillaume Vogin a top-rated expert for Adult Soft Tissue Sarcoma?

MediFind is an objective health platform that identifies experts based on real-world data. Guillaume Vogin is classified as an Advanced expert for Adult Soft Tissue Sarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Guillaume Vogin participate in research or clinical trials?

Yes. Guillaume Vogin has published 66 articles and abstracts on conditions like Adult Soft Tissue Sarcoma. You can view a list of Guillaume Vogin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Vogin's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile